Lymphoma Management Updates for 2021 - SPOC

This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.

Learning Objectives

  • Identify new indications for CAR-T therapy: rel/ref Mantle cell and follicular lymphoma
  • Discuss mechanism of action of polatuzumab vedotin
  • Recall long-term data for use of tafasitimab + lenalidomide in rel/ref DLBCL

 

Taking the Course

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Course opens: 
02/17/2022
Course expires: 
02/16/2023
Rating: 
0
Photo of Anne W. Beaven, MD 

Anne W. Beaven, MD

Associate Professor of Medicine
Vice Chief of Operations, Division of Hematology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

Anne W. Beaven, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.

 

To receive free Continuing Education Credit for this Self-Paced, Online Course:

  • Watch the video
  • Complete the assessment with a score of 80% or better
  • Complete the evaluation
  • Download the appropriate certificate

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency.

1.00 AMA PRA Category 1 Credit™
The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

1.00 AMA PRA Category 1 Credit™
Non-physicians will receive credit for time spent in an activity designated for AMA PRA Category 1 Credit™. Most health care professionals can use this credit, but UNC CPD cannot guarantee that licensing boards and other organizations will accept it. If you are not sure, please check with your organization to make sure that AMA PRA Category 1 Credits are accepted.

1.00 NCPD/CNE
The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

1.00 ACPE Pharmacist
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**

1.00 ACPE Pharmacy Tech
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**

1.00 CTR
Approved by the National Cancer Registrars Association (NCRA).

1.00 ASRT
Approved by the American Society of Radiologic Technologists (ASRT).

In most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to achieve a score of 80% or better on an assessment for the Self-Paced, Online Course to receive CE credit. Please contact your individual accreditation agencies for more details.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Please login or register to take this course.